Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors
NGM Biopharmaceuticals, Inc
NGM Biopharmaceuticals, Inc
Wellmarker Bio
Celon Pharma SA
Newish Technology (Beijing) Co., Ltd.
Beijing InnoCare Pharma Tech Co., Ltd.
Power Life Sciences Inc.
Wellmarker Bio
Delcath Systems Inc.
SpeciCare
Guangdong Zhongsheng Pharmaceutical Co., Ltd.
Taizhou EOC Pharma Co., Ltd.
Immunitor LLC
Immunitor LLC